Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.

Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.

Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.

Potential Risks of TTTS

If left untreated, TTTS can have devastating consequences. Medical research indicates that:

• 90% of the cases of untreated TTTS lead to loss of one or both twins.
• Despite treatment, only a 70% survival rate for both twins is assured.
• Severe forms can result in preterm labor, cardiac failure in the recipient twin, and organ failure in the donor twin.
• Complications in long-term survivors include neurological damage and developmental delay in surviving infants.

TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.

Why Identical Twin Pregnancies Are More Complicated

Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.

Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.

Other Twin Pregnancy Health Risks

Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:

1. Premature Birth

Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.

2. Gestational Hypertension and Preeclampsia

Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.

3. Anemia

Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.

4. Birth Defects

According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.

5. Amniotic Fluid Imbalances

When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.

6. Postpartum Hemorrhage

Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.

Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."

Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.

Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.

The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.

About 35 people have tested positive for Chandipura virus, while 22 have lost their lives due to the insect-borne virus, said Gujarat Health Minister Praful Pansheriya.

Speaking to the media, Pansheriya added that seven others are currently undergoing treatment in ICUs with ventilator and oxygen support under the supervision of super-specialist doctors.

The state health department has intensified surveillance and testing efforts across affected areas and is working to identify and isolate suspected cases.

What Is Chandipura Virus?

Chandipura virus (CHPV) is an insect-borne virus belonging to the Rhabdoviridae family and the Vesiculovirus genus. It was first identified in 1965 in Chandipura village in Maharashtra.

The virus is transmitted primarily through phlebotomine sandflies, although mosquitoes and ticks may also play a role in transmission.

Also read: 6-in-1 Vaccine Could Make India's Childhood Immunization Program More Efficient, Cut Costs: Health Ministry Study

Most cases have been reported from central and western India, particularly during the monsoon and post-monsoon months when sandfly populations increase.

While some infections remain mild, the virus can rapidly invade the brain, causing acute encephalitis (brain inflammation), seizures, coma, and even death, especially in children.

"In some children, Chandipura virus can cause severe brain inflammation and become life-threatening within a short period," said Dr. Kanchankumar Bhagyawant, Consultant Paediatrician and Neonatologist at Ruby Hall Clinic, Pune.

Symptoms Of Chandipura Virus Infection

Symptoms usually begin suddenly and may initially resemble other viral illnesses. The expert urged to watch out for:

• Sudden high fever
• Severe headache
• Vomiting
• Excessive sleepiness or reduced activity
• Irritability or behavioural changes
• Convulsions or seizures
• Loss of consciousness in severe cases.

"Parents should never ignore a fever lasting more than three days if it is accompanied by repeated vomiting, seizures, confusion, or excessive sleepiness. Seeking immediate medical care can be lifesaving," Dr. Bhagyawant said.

Why Are Children More At Risk?

Read More: India Records 20,138 Organ Transplants In 2025; Deceased Donor Transplants Reach 3,526

According to Dr. Bhagyawant, children below 15 years, especially those living in rural and semi-rural areas, are the most vulnerable to Chandipura virus infection. Although adults can be infected, severe disease is far less common.

Children are at greater risk because of several factors:

• Immature immune system: Young children have fewer antibodies and are less able to fight new viral infections.
• Higher exposure: Outdoor play increases contact with sandflies, particularly during the monsoon.
• Limited prior immunity: Most children have not been previously exposed to the virus.
• Rapid disease progression: The virus can multiply quickly, overwhelming a child's immune system.
• Developing brain: Children's brains are more vulnerable to encephalitis and neurological damage.
• Delayed diagnosis: Early symptoms resemble common viral infections, delaying treatment.
• Limited healthcare access: Rural areas may have fewer diagnostic and treatment facilities.
• Poor vector control: Inadequate measures to control sandflies increase the risk of transmission.

How Can Chandipura Virus Infection Be Prevented?

There is currently no specific antiviral treatment or vaccine for Chandipura virus. Prevention focuses on avoiding insect bites and reducing exposure to sandflies.

Dr. Bhagyawant recommended:

• Use mosquito or sandfly nets, especially for children at night.
• Apply age-appropriate insect repellents.
• Dress children in full-sleeved clothing and long pants.
• Keep homes and surroundings clean.
• Eliminate stagnant water and improve sanitation around homes and animal shelters.
• Install window screens where possible.
• Seek immediate medical attention if a child develops a high fever along with vomiting, seizures or altered consciousness.

Indian food regulatory body FSSAI has barred the sale of select products produced by one of the biggest FMCG companies in India.

The Food Safety and Standards Authority of India prohibited Dabur India from selling its popular household products like honey, cow ghee, and edible oils with '100 percent' claims.

FSSAI's Crackdown On Dabur India Products

On Monday, FSSAI shared a social media post, announcing that it has banned the sale of a few products produced by Dabur India over misleading claims.

In a Tweet, it said that the FMCG giant has been asked to stop selling products like honey, apple cider vinegar, virgin coconut oil, sesame oil, cow ghee, coconut water, coconut milk, and other products due to various non-compliances.

The following violations were listed by the food regulatory body:

Misleading '100%' Claims

FSSAI said that some Dabur products were being sold on the company's website with misleading '100% percent' claims like '100% Natural', '100% Pure', '100% Purity Guaranteed', '100% Organic, and '100% Tender Coconut Water'.

FSSAI said that Dabur Homemade Coconut Milk was being sold with the claim '100% Purity', which is in violation with its rules.

According to FSS (Advertising & Claims) Regulations, 2018, the use of claims with '100%' is prohibited as it's an ambiguous term which cannot be verified. It further said that such claims can mislead the consumers.

Also read: FSSAI Bans Some Liquor Produced by India's Largest Alcohol Company Over Artificial Flavouring

Misuse Of Jaivik Bharat Logo

Furthermore, its products like Dabur Himalayan Organic Apple Cider Vinegar and Dabur Organic Honey were found showcasing Jaivik Bharat Logo without an organic endorsement by FSSAI.

The Jaivik Bharat logo is specifically issued to authentic organic food products in order to distinguish them from non-organic items. It is meant to show compliance with Indian organic standards.

The regulatory body said that by doing so, the company violated FSS (Organic Foods) Regulations, 2017.

Also read: No Junk Food Near Schools! Maharashtra FDA Bans Sale Of Foods & Drinks High In Fat, Salt & Sugar

Failure To Respond To Earlier Notice

This is not the first time FSSAI has brought these violations to the company's attention. In its notice, it said that Dabur paid no heed to an earlier notice which directed them to discontinue products with '100% claims'.

It said that the company failed to take "satisfactory corrective action".

Besides prohibiting the sale of these products, FSSAI has asked Dabur to submit an Action Taken Report (ATR) within 15 days.

Also read: 60% Urban Indians Not Confident About Ghee Purity Despite FSSAI Crackdown

Part Of A Broader Strategy

FSSAI's action is part of its broader strategy to stop the sale of products with misleading claims and brand names.

Recently, show-cause notices were sent to brands like Lotte India, Kubera Foods, and Ferns N Petals Pvt Ltd over allegedly misleading claims such as "100% Natural," "100% Vegetarian," and chocolate labelling issues.

It also flagged Heritage Fresh Paneer for using the term "Fresh Paneer" to market its products.

In June, brands like Nestlé, KFC, Open Secret, Emami Healthy & Tasty, Storia Juice, Two Brothers Organic Farms, Healthy Master, Neuherbs, The Health Factory, Troovy, Healthy Choice, Organic Wisdom, Shine Organic, World of Organic, and Lota Water were sent notices for misleading brand names and health claims like "organic," "healthy," "zero maida," and similar marketing claims that may violate labelling regulations.

The currently used breast cancer screening referral criteria at the NHS are missing up to 95% of women under 50 who are at higher risk of developing breast cancer in the next decade, according to a new study.

Published in the British Journal of Cancer, the study found that a more comprehensive, personalized risk assessment could identify 8 times as many women at risk as the current NICE guidelines.

Current Screening Criteria

Also read: New York Reports 3 Suspected Rabbit Fever Cases: What Is Tularemia?

In England, women at higher risk of breast cancer are typically identified after being referred by their GP based on family history, following criteria set by the National Institute for Health and Care Excellence (NICE), under the NHS.

The researchers from the University of Cambridge and The Institute of Cancer Research, London, analyzed data from 1,258 women under the age of 50.

They found that the criteria would refer only 1.4% of women for specialist assessment and identify just 4.4% of women who went on to develop breast cancer within the next 10 years.

Why Personalized Assessment Is Better?

The researchers then evaluated BOADICEA, a multifactorial risk model that combines:

• Family history
• Lifestyle factors
• Reproductive history
• Genetic information

Using this model, 26.5% of women were classified as having above-average risk and referred for further assessment. This approach identified 34.8% of women who developed breast cancer within the following 10 years—around eight times more than the current NICE criteria.

One major reason for the gap is that 73% of women under 50 who developed breast cancer had no family history of the disease, making them unlikely to qualify for referral under existing guidelines.

"We need to get better at identifying women at highest risk of breast cancer so that we can intervene early, when there are more options for treating, or even preventing, their disease," said Dr Juliet Usher-Smith from the Department of Public Health and Primary Care at the University of Cambridge.

Read More: UK Woman Becomes World-First To Receive Experimental Cell Therapy For Ovarian Cancer

Proactive Screening Matters

A second study by the same research team found strong public support for proactive breast cancer risk assessments for women aged 30 to 49, instead of relying on women to seek GP referrals because of family history.

They found that women preferred:

• Proactive invitations for risk assessment
• Comprehensive risk models such as BOADICEA
• Genetic testing where appropriate
• Assessing all women rather than only those with a family history

Dr Sowmiya Moorthie, Senior Strategic Evidence Manager at Cancer Research UK, said broader risk assessment could help more women receive personalized care. However, she noted that further research is needed to understand the impact on NHS staffing, equipment, and patient experience, while ensuring any new approach remains accessible and equitable.

She also emphasized that maintaining a healthy weight, limiting alcohol intake, and seeking medical advice for any unusual breast changes remain important ways to reduce risk and improve outcomes through early diagnosis.

Global Breast Cancer Burden

Breast cancer is the most common cancer worldwide, with steady increases in incidence over the last few decades. It accounts for around one in four cases of cancer and 15 per cent of cancer deaths in women, and is one of the leading causes of death in women under 50.

Breast cancer is the most common cancer in the UK, with around 59,400 new cases diagnosed annually and roughly 11,200 deaths each year. About one in seven women in the UK develops the disease in their lifetime, though survival rates are high, with nearly 90% surviving for five years or more.